Chemed Corp (CHE)

Nov 8, 2026

Alps Advisors Inc. significantly reduced its holdings in Chemed Corporation by 24% in the third quarter, selling 9,809 shares and ending with 30,986 shares valued at $15.65 million. Despite insider selling by executives, Chemed reported strong quarterly results, beating EPS consensus and increasing revenue by 10.6% year over year. The stock currently holds an average analyst rating of "Hold" with a target price of $603.00.

Nov 6, 2026

Chemed Corporation (NYSE: CHE) announced a quarterly dividend of $0.70 per share, maintaining its previous payout. The company is considered modestly undervalued by GuruFocus' GF Value™ and has a strong GF Score™ of 86/100, reflecting solid financial health and profitability, despite recent net insider selling.

Nov 2, 2026

ProShare Advisors LLC significantly reduced its stake in Chemed Corporation by 23.3% in the third quarter, selling 16,516 shares and retaining 54,245 shares valued at approximately $27.4 million. Despite institutional ownership by 95.85% of the stock, analyst sentiment is mixed but improving, with a consensus "Hold" rating and an average target price of $603. Chemed reported strong quarterly earnings, beating estimates, with revenue up 10.6% year-over-year, and increased its quarterly dividend to $0.70 per share.

Oct 28, 2026

Chemed Corp. (CHE) reported a third-quarter profit of $71.6 million, or $5.45 per share. Adjusted earnings for the Cincinnati-based company, which operates Roto-Rooter and Vitas Healthcare, were $6.75 per share, with revenue reaching $690.9 million.

Oct 28, 2026

Chemed Corporation reported robust financial results for Q3 2026, with total revenue increasing by 10.6% and adjusted diluted EPS rising by 28.1% year-over-year. The VITAS Healthcare segment saw a 12.2% revenue increase due to ADC growth and cost control, while Roto-Rooter's revenue grew 7.5%, supported by acquisitions and strong same-store sales despite higher marketing costs. The company completed $66 million in share repurchases and remains confident in exceeding its full-year 2026 adjusted EPS guidance, with a continued focus on strategic acquisitions to drive long-term growth.